Earl Rubin, MD
Axe de recherche primaire:
Infection et immunité
Courriel:
Courriel Le but de la recherche:
Les travaux de recherche portent sur le développement de vaccins et d’essais cliniques, ainsi que des diagnostics virologiques rapides, et l’utilisation d’antibiotiques.
Emplacement:
Montreal Children's Hospital Publications:
Tapiero B, Halperin S, Dionne M, Meekison W, Diaz-Mitoma F, Zigler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Harrison D, Tomovici A. Safety and immunogenicity of a toddler dose of a liquid hexavalent DtaP-IPV-Hib-HepB vaccine following primary series. European Society for Pediatric Infectious Diseases (ESPID) Annual Conference, Brussels, Belgium, June 9-13, 2009
Tapiero B, Halperin S, Dionne M, Meekison W, Diaz-Mitoma F, Zigler P, Rubin E, Embree J, Bhuyan P, Li M., Tomavici A. Safety and Immunogenicity of a novel hexavalent DtaP-IPV-Hib-HepB vaccine given at 2, 4 and 6 months of age. Infectious Diseases Society of America (IDSA), Washington DC, Oct 24-28, 2008
Michelle Barton et al, and the Canadian Neonatal Candidiasis Study Investigators (including Rubin EE). Candidiasis in Neonatal Intensive Care Units: A Descriptive Cohort of a Canadian MultiCentre Prospective Study. Infectious Diseases Society of America (IDSA), Toronto, Canada, Oct 12-15, 2006
